vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Navigator Holdings Ltd. (NVGS). Click either name above to swap in a different company.

Navigator Holdings Ltd. is the larger business by last-quarter revenue ($129.6M vs $75.1M, roughly 1.7× MEDIFAST INC). On growth, Navigator Holdings Ltd. posted the faster year-over-year revenue change (-11.6% vs -36.9%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Navigator Holdings Ltd. is a global maritime transport firm specializing in liquefied gas carrier operations. It offers seaborne transport for liquefied petroleum gas, ammonia, ethylene and other specialty liquefied gases, serving clients across the global energy, petrochemical and industrial manufacturing sectors.

MED vs NVGS — Head-to-Head

Bigger by revenue
NVGS
NVGS
1.7× larger
NVGS
$129.6M
$75.1M
MED
Growing faster (revenue YoY)
NVGS
NVGS
+25.3% gap
NVGS
-11.6%
-36.9%
MED

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
MED
MED
NVGS
NVGS
Revenue
$75.1M
$129.6M
Net Profit
$21.5M
Gross Margin
69.4%
Operating Margin
-10.4%
15.8%
Net Margin
16.5%
Revenue YoY
-36.9%
-11.6%
Net Profit YoY
-7.7%
EPS (diluted)
$-1.64
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
NVGS
NVGS
Q4 25
$75.1M
Q3 25
$89.4M
Q2 25
$105.6M
$129.6M
Q1 25
$115.7M
Q4 24
$119.0M
Q3 24
$140.2M
Q2 24
$168.6M
$146.7M
Q1 24
$174.7M
Net Profit
MED
MED
NVGS
NVGS
Q4 25
Q3 25
$-2.3M
Q2 25
$2.5M
$21.5M
Q1 25
$-772.0K
Q4 24
Q3 24
$1.1M
Q2 24
$-8.2M
$23.2M
Q1 24
$8.3M
Gross Margin
MED
MED
NVGS
NVGS
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
NVGS
NVGS
Q4 25
-10.4%
Q3 25
-4.6%
Q2 25
-1.0%
15.8%
Q1 25
-1.1%
Q4 24
0.6%
Q3 24
1.5%
Q2 24
-4.7%
26.9%
Q1 24
4.5%
Net Margin
MED
MED
NVGS
NVGS
Q4 25
Q3 25
-2.5%
Q2 25
2.3%
16.5%
Q1 25
-0.7%
Q4 24
Q3 24
0.8%
Q2 24
-4.8%
15.8%
Q1 24
4.8%
EPS (diluted)
MED
MED
NVGS
NVGS
Q4 25
$-1.64
Q3 25
$-0.21
Q2 25
$0.22
$0.31
Q1 25
$-0.07
Q4 24
$0.08
Q3 24
$0.10
Q2 24
$-0.75
$0.32
Q1 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
NVGS
NVGS
Cash + ST InvestmentsLiquidity on hand
$167.3M
$238.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$1.2B
Total Assets
$248.0M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
NVGS
NVGS
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
$238.1M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Stockholders' Equity
MED
MED
NVGS
NVGS
Q4 25
$198.9M
Q3 25
$214.7M
Q2 25
$216.0M
$1.2B
Q1 25
$211.0M
Q4 24
$210.1M
Q3 24
$207.3M
Q2 24
$205.3M
$1.2B
Q1 24
$211.0M
Total Assets
MED
MED
NVGS
NVGS
Q4 25
$248.0M
Q3 25
$268.2M
Q2 25
$269.3M
$2.4B
Q1 25
$280.0M
Q4 24
$284.2M
Q3 24
$291.2M
Q2 24
$293.5M
$2.1B
Q1 24
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
NVGS
NVGS
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
NVGS
NVGS
Q4 25
$-5.3M
Q3 25
$12.1M
Q2 25
$-3.4M
Q1 25
$3.4M
Q4 24
$-4.9M
Q3 24
$9.1M
Q2 24
$13.1M
Q1 24
$7.3M
Free Cash Flow
MED
MED
NVGS
NVGS
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
MED
MED
NVGS
NVGS
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
MED
MED
NVGS
NVGS
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
MED
MED
NVGS
NVGS
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

NVGS
NVGS

Time Charters$91.5M71%
Voyage Charters$25.7M20%
Other$12.4M10%

Related Comparisons